FibroGen is listed on the NASDAQ Global Market under the ticker symbol FGEN.

31572Q881

FibroGen is incorporated in the State of Delaware.

FibroGen, Inc., headquarters are located at 350 Bay St, Ste 100 # 6009, San Francisco, CA 94133.

Shares may be purchased or sold through a stockbroker of your choice.

No, FibroGen, Inc., does not have a direct stock purchase plan. Shares may be purchased through a stockbroker of your choice.

FibroGen, Inc., does not foresee paying a dividend in the near future.

American Stock Transfer & Trust Company LLC 
6201 15th Avenue
 Brooklyn, NY 11219 
www.amstock.com 
[email protected]
Tel: 800-937-5449 (US toll-free) 
Tel: 718-921-8124 (from outside the US)

Our shares are uncertificated. However, communication regarding change of address should be directed to our transfer agent, American Stock Transfer & Trust Company LLC, if you hold shares directly, or with your stockbroker if you purchased shares on the open market.

PricewaterhouseCoopers LLP 
488 Almaden Blvd, Suite 1800 
San Jose, CA 95110

You may contact FibroGen’s Investor Relations team at [email protected].

You can find the IRS Form 8937 here.